Santillan-Doherty Patricio, Cuellar-Rodríguez Jennifer, Argote-Greene Luis Marcelo, Hernández-Calleros Jorge
Thoracic Surgical Service, Department of Surgery, Salvador Zubirán National Institute of Medical Sciences and Nutrition, Vasco de Quiroga 15, Tlalpan 14000, D.F., Mexico.
World J Surg. 2002 Jan;26(1):43-8. doi: 10.1007/s00268-001-0179-0. Epub 2001 Nov 22.
Video technology has revolutionized thoracoscopy dramatically, considerably increasing its indications. The clinical charts of patients who underwent a video-thoracoscopic procedure during a 6-year period were reviewed. Any patient in whom lung wedge resection for diffuse disease or an indeterminate nodule was performed met the inclusion criteria. Early and long-term outcomes were analyzed. A total of 310 thoracoscopic procedures were performed in the 250 patients reviewed. Of these patients, 60 presented with diffuse lung disease and 71 with an indeterminate pulmonary nodule. The total morbidity among diffuse disease patients was 5% (one intercostal vessel hemorrhage and two air leaks). Overall mortality for this group was 11% and was related to previous respiratory status and underlying disease. Patients not requiring preoperative mechanical ventilation ended up requiring it postoperatively, for a crossover rate of 23%. There was no morbidity or mortality in patients who did not require mechanical ventilation. The therapeutic impact index (defined as the total number of patients divided by the patients in whom initiation or withdrawal of specific treatment was due to the biopsy result) for diffuse lung disease was 0.9. Regarding lung nodule resection, early morbidity was present in one patient, who developed a persistent air leak. Late morbidity was present in three patients, who developed persistent intercostal pain. Total morbidity was 5.6%. No mortality was observed for this group. Nonanatomic wedge resection via video-thoracoscopy for diffuse pulmonary disease and indeterminate lung nodule is feasible using minimally invasive methods. Morbidity and mortality are related to the underlying disease and the respiratory status; they are not necessarily due to the procedure.
视频技术极大地革新了胸腔镜检查,显著增加了其适应症。回顾了在6年期间接受视频胸腔镜手术的患者的临床病历。任何因弥漫性疾病或肺结节性质不明而接受肺楔形切除术的患者均符合纳入标准。分析了早期和长期结果。在纳入回顾的250例患者中,共进行了310例胸腔镜手术。其中,60例患有弥漫性肺疾病,71例有性质不明的肺结节。弥漫性疾病患者的总发病率为5%(1例肋间血管出血和2例漏气)。该组患者的总体死亡率为11%,与既往呼吸状况和基础疾病有关。术前无需机械通气的患者术后最终需要机械通气,交叉发生率为23%。无需机械通气的患者无发病率或死亡率。弥漫性肺疾病的治疗影响指数(定义为患者总数除以因活检结果而开始或停止特定治疗的患者数)为0.9。关于肺结节切除术,1例患者出现早期并发症,发生持续性漏气。3例患者出现晚期并发症,发生持续性肋间疼痛。总发病率为5.6%。该组未观察到死亡病例。通过视频胸腔镜对弥漫性肺疾病和性质不明的肺结节进行非解剖性楔形切除术采用微创方法是可行的。发病率和死亡率与基础疾病和呼吸状况有关;不一定是手术所致。